Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger CW-type and PWWP domain-containing protein 1 (ZCWPW1) is a dual histone methylation reader protein specific for PRDM9-catalyzed marks (H3K4me3 and H3K36me3), playing essential roles in male fertility and spermatogenesis[1][2][7]. It facilitates the repair of meiotic double-strand breaks and is required for proper progression of meiosis prophase I in male germ cells[2][3][7]. The protein contains a CW-type zinc finger domain, which acts as a histone tail modification reader, and a PWWP domain associated with chromatin binding[1][2][7]. ZCWPW1 is encoded by the ZCWPW1 gene, expressed in testis and several tissues, and linked to disease roles such as ciliary dyskinesia, frontotemporal dementia/ALS, and male infertility[2][5][7]. There are currently no known drugs targeting ZCWPW1, and its modulation might present safety risks related to reproductive health.
Not applicable/none identified (no current drugs directly targeting ZCWPW1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger CW-type and PWWP domain-containing protein 1 (ZCWPW1).